Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Boxer Capital, LLC
San DiegoSeed–Late Stage
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
Stonebridge Ventures
SeoulSeed–Late Stage$743K – $33M
3 people
CDF-Capital
ShenzhenSeed–Late Stage
City Side Ventures LLC
BirminghamSeed–Late Stage$150K – $10M
3 people
Ela Capital
TorontoPre-Seed–Growth
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
Ikarian Capital
DallasPre-Seed–Late Stage
Impulsora de Innovacion Mexico
Mexico CityPre-Seed–Growth$1M
Laval Innov
LavalPre-Seed–Late Stage
MagogTechnopole
MagogPre-Seed–Late Stage
North Forge Technology Exchange
WinnipegPre-Seed–Late Stage
Northwestern Ontario Innovation Centre
Thunder BayPre-Seed–Late Stage
Seoul Investment Partners
SeoulSeed–Late Stage
Skolkovo Foundation
MoscowPre-Seed–Growth
Technology Innovation Agency
PretoriaPre-Seed–Growth
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Late Stage$1.1M – $198M
1 person
Alibaba Entrepreneurs Fund
Hong KongSeed–Late Stage$1.2M – $150M
2 people
Mizuho Capital
TokyoPre-Seed–Late Stage$1.5M – $340M
1 person
Good Startup
BrusselsSeed–Late Stage
5 people
Oceanpine Capital
BeijingSeed–Late Stage
5 people
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Baidu Ventures
BeijingSeed–Growth$1.4M – $145M
2 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.
